Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -320,622 | -766,628 | -520,121 | -307,291 | -140,718 |
| Depreciation Amortization | 2,742 | 10,426 | 3,390 | 457 | -39 |
| Accounts payable and accrued liabilities | -269 | 19,906 | -1,761 | -19,638 | -29,163 |
| Other Working Capital | -2,910 | -3,452 | 16,251 | -15,824 | -49,515 |
| Other Operating Activity | 40,434 | 84,171 | 71,496 | 54,856 | 53,161 |
| Operating Cash Flow | $-280,625 | $-655,577 | $-430,745 | $-287,440 | $-166,274 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -584,129 | -1,211,499 | -918,850 | -663,535 | -314,485 |
| PPE Investments | -2,107 | -13,713 | -11,059 | -7,235 | -5,424 |
| Sale Of Investment | 365,513 | 1,705,826 | 1,289,631 | 901,100 | 464,553 |
| Other Investing Activity | -12,687 | -43,260 | -37,493 | -29,271 | -21,327 |
| Investing Cash Flow | $-233,410 | $437,354 | $322,229 | $201,059 | $123,317 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 610,878 | N/A | 9,590 | 9,284 | 6,049 |
| Other Financing Activity | -9,295 | 2,014 | -9,984 | -6,007 | -5,290 |
| Financing Cash Flow | $601,583 | $2,014 | $-394 | $3,277 | $759 |
| Exchange Rate Effect | -664 | 2,439 | 2,263 | 1,972 | 1,172 |
| Beginning Cash Position | 175,425 | 389,195 | 389,195 | 389,195 | 389,195 |
| End Cash Position | 262,309 | 175,425 | 282,548 | 308,063 | 348,169 |
| Net Cash Flow | $86,884 | $-213,770 | $-106,647 | $-81,132 | $-41,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -280,625 | -655,577 | -430,745 | -287,440 | -166,274 |
| Capital Expenditure | -2,107 | -13,713 | -11,059 | -7,235 | -5,424 |
| Free Cash Flow | -282,732 | -669,290 | -441,804 | -294,675 | -171,698 |